German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures - Summary - MDSpire

German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures

  • By

  • Justine Schoch

  • Kathrin Haunschild

  • Angelina Strauch

  • Kai Nestler

  • Hans Schmelz

  • Pia Paffenholz

  • David Pfister

  • Thorsten Persigehl

  • Axel Heidenreich

  • Tim Nestler

  • April 4, 2023

  • 0 min

Share

Objective:

To evaluate practice patterns among German specialists in treating testicular germ cell tumors (GCTs) regarding the assessment of retroperitoneal lymph nodes and adherence to specific clinical guidelines.

Key Findings:
  • Response rate was 93% with 50 respondents, primarily urologists (84%), indicating strong engagement in the survey.
  • Inconsistency in lymph-node size assessment: 54.7% of urologists used short-axis diameter (SAD) while 45.3% used long-axis diameter (LAD), potentially leading to varied clinical decisions.
  • 71.4% of oncologists assessed lymph-node size based on SAD, highlighting a trend among specialists.
  • Only 17% of urologists included lymph-node volume in their assessments; none of the oncologists did, suggesting a gap in comprehensive evaluation.
Interpretation:

The study highlights significant inconsistencies in the assessment of lymph-node metastasis among specialists, which may adversely affect clinical staging and treatment decisions, potentially leading to suboptimal patient outcomes.

Limitations:
  • Survey responses may not fully represent all German specialists due to non-response, which could skew the findings.
  • Potential biases in self-reported practices and interpretations may affect the reliability of the data.
Conclusion:

Standardizing guidelines and imaging practices is essential to improve consistency in the assessment of retroperitoneal lymph nodes in GCT treatment, and specific corrective measures should be implemented to address identified discrepancies.

Original Source(s)

Related Content